ConductScience.org, home

Paper2895840

Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.

Mindel A and 5 others. Lancet, 1988. Cited by 105 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Papers, record 2895840. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2895840

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.
PubMed
Journal
Lancet
PubMed
Year
1988
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
105
iCite
Relative citation ratio, by iCite
4.17
iCite
Revised in PubMed
2021-12-03
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mindel AA
2Faherty AA
3Carney OO
4Patou GG
5Freris MM
6Williams PP

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcyclovirMajor topic
Herpes GenitalisMajor topic
Immunosuppression TherapyMajor topic
Administration, Oral
Adult
Bilirubin
Clinical Trials as Topic
Drug Administration Schedule
Female
Headache
Humans
Male
Patient Compliance
Random Allocation
Recurrence
Tablets
Time Factors

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.

PMIDTitleJournalYearIn PapersSource
41184552A portable poison exon for small-molecule control of mammalian gene expression.Nat Methods2025https://conductscience.org/library/papers/41184552PubMed
40431612Immunological Control of Herpes Simplex Virus Type 1 Infection: A Non-Thermal Plasma-Based Approach.Viruses2025https://conductscience.org/library/papers/40431612PubMed
396202712024 European guidelines for the management of genital herpes.J Eur Acad Dermatol Venereol2025https://conductscience.org/library/papers/39620271PubMed
39374063British Association of Sexual Health and HIV UK national guideline for the management of anogenital herpes, 2024.Int J STD AIDS2025https://conductscience.org/library/papers/39374063PubMed
33239478Successful treatment of elephant endotheliotropic herpesvirus infection in an Asian elephant (Elephas maximus) calf by oral acyclovir medication: Case report.J Vet Med Sci2021https://conductscience.org/library/papers/33239478PubMed
26983589Protection from lethal herpes simplex virus type 1 infection by vaccination with a UL41-deficient recombinant strain.Fukushima J Med Sci2016https://conductscience.org/library/papers/26983589PubMed
25086573Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/25086573PubMed
21865349Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.J Antimicrob Chemother2011https://conductscience.org/library/papers/21865349PubMed
18159421Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses.Can J Infect Dis2003https://conductscience.org/library/papers/18159421PubMed
17284082Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.Drugs2007https://conductscience.org/library/papers/17284082PubMed
15813644Psychological symptoms associated with genital herpes virus infections: epidemiology and approaches to management.CNS Drugs2005https://conductscience.org/library/papers/15813644PubMed
15170001Patient satisfaction with care for genital herpes: insights from a global survey.Sex Transm Infect2004https://conductscience.org/library/papers/15170001PubMed
11994034Genital herpes simplex virus infection in the adolescent: special considerations for management.Paediatr Drugs2002https://conductscience.org/library/papers/11994034PubMed
11152015Current recommendations for the treatment of genital herpes.Drugs2000https://conductscience.org/library/papers/11152015PubMed
9880471Genital herpes: review of the epidemic and potential use of type-specific serology.Clin Microbiol Rev1999https://conductscience.org/library/papers/9880471PubMed
8282300The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes.Genitourin Med1993https://conductscience.org/library/papers/8282300PubMed
7917073Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection.Drug Saf1994https://conductscience.org/library/papers/7917073PubMed
7512902Genital herpes. A guide to pharmacological therapy.Drugs1994https://conductscience.org/library/papers/7512902PubMed
2766169O'Brien-Bell leaves office with his concerns about two-tier system growing. Interview by Terry Moran.CMAJ1989https://conductscience.org/library/papers/2766169PubMed
2653790Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.Drugs1989https://conductscience.org/library/papers/2653790PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2895840

GET https://conductscience.org/api/papers/v1/2895840/cited_by?page=2